0001104659-21-053237.txt : 20210421
0001104659-21-053237.hdr.sgml : 20210421
20210421171657
ACCESSION NUMBER: 0001104659-21-053237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210419
FILED AS OF DATE: 20210421
DATE AS OF CHANGE: 20210421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SQUINTO STEPHEN P
CENTRAL INDEX KEY: 0001231954
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38807
FILM NUMBER: 21842476
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS INC
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd.
CENTRAL INDEX KEY: 0001534248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
BUSINESS PHONE: 972-77-331-0156
MAIL ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
FORMER COMPANY:
FORMER CONFORMED NAME: Anchiano Therapeutics Ltd.
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: BioCancell Ltd.
DATE OF NAME CHANGE: 20111104
4
1
tm2113689d6_4.xml
FORM 4
X0306
4
2021-04-19
0
0001534248
Chemomab Therapeutics Ltd.
CMMB
0001231954
SQUINTO STEPHEN P
930 5TH AVE, APT 18A
NEW YORK
NY
10021
1
0
0
0
American Depositary Shares
47938
D
Option to Purchase American Depositary Shares
27.26
2021-04-19
4
A
0
23768
0
A
2031-04-19
American Depositary Shares
23768
23768
D
Option to Purchase American Depositary Shares
0.67
2025-11-18
American Depositary Shares
424
424
D
Option to Purchase American Depositary Shares
0.8
2026-09-13
American Depositary Shares
2109
2109
D
Option to Purchase American Depositary Shares
1.49
2027-11-19
American Depositary Shares
21095
21095
D
Option to Purchase American Depositary Shares
1.49
2028-10-21
American Depositary Shares
32928
32928
D
Option to Purchase American Depositary Shares
1.48
2030-11-19
American Depositary Shares
40362
40362
D
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.
14,059 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 7,036 of these options will vest and become exercisable in three installments, with 1/3 of the options vesting on each three month anniversary commencing on May 16, 2021, subject to the Reporting Person's continued service.
5,042 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 35,320 of these options will vest and become exercisable in seven installments, with 1/7 of the options vesting on each three month anniversary commencing on May 19, 2021, subject to the Reporting Person's continued service.
/s/ Matthew Rudolph, Esq., Attorney-in-Fact for Stephen Squinto
2021-04-21